Please use this identifier to cite or link to this item: https://ir.iimcal.ac.in:8443/jspui/handle/123456789/4712
Title: Covid 19 pandemic, patents and licensing models: The need for a balanced approach
Authors: Unni, V.K.
The Times Now
Keywords: Covid 19
Virus
Indian Patents Act 1970
Act Amendment
Patent Office
Issue Date: 5-May-2020
Publisher: The Times Now
Abstract: IPA contains elaborate provisions on compulsory licenses and the existing provisions were included by way of the 2002 Amendment to IPA. While the entire world is awaiting results of the trial involving the drug Remdesivir to treat patients affected by the Covid 19 pandemic, serious concerns have been raised in countries like India where the drug has been patented. Gilead Incorporated’s patented invention titled “Compounds for treating Filoviridae virus infections” relates generally to methods and compounds for treating Filoviridae virus infections and particularly to methods and nucleosides for treating Ebola virus, Marburg virus and Cueva virus. Gilead filed its patent application with the Indian patent office in April 2017 and the patent had been granted in February 2020. Thus, Gilead now has the exclusive right to prevent third parties from the act of making, using, selling or importing that product in India under section 48 of the Indian Patents Act 1970 (IPA). However there is no need to panic at this stage as IPA contains robust safeguards to deal with such situations and one of the most efficient legal remedy is the provisions relating to compulsory licensing of patented inventions.
Description: Source: News: Online: The Times Now Dated: 05-05-2020
URI: https://www.timesnownews.com/business-economy/industry/article/covid-19-pandemic-patents-and-licensing-models-the-need-for-a-balanced-approach/587213
https://ir.iimcal.ac.in:8443/jspui/handle/123456789/4712
Appears in Collections:IIMC Stakeholders

Files in This Item:
File Description SizeFormat 
ppm-7.pdfCovid 19 pandemic, patents and licensing models: The need for a balanced approach422.23 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.